Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 |Industry: Pharmaceuticals
|Expensive Performer
556.00 -8.00 (-1.42%)
NSE Jul 18, 2018 15:31
Volume: 567.5K
 
Durability score
40/100
Medium Financial Strength
Valuation score
25.7/100
Expensive Valuation
Momentum score
38.7/100
Neutral Momentum
Market Capitalizati...
15688.6
High in industry
AVG Broker Target
691.6
24.39% upside
PE TTM Price to Ear...
19.5
Above industry median.
Technicals | Save image
Fetching latest news from server
Poll
VOTE: What's your call on Glenmark Pharmaceuticals Limited?
Total Votes: 75
BUY
SELL
HOLD
81.33%
12.0%
6.67%
  • Stock Price (556.00) crossed below 150 Day SMA (562.71) on 18 July, 2018
  • Stock Price (565.10) crossed above 50 Day SMA (554.65) on 17 July, 2018
  • Stock Price (565.10) crossed above 100 Day SMA (553.36) on 17 July, 2018
  • Stock Price (584.25) crossed above 200 Day SMA (572.91) on 14 June, 2018
  • HDFC Securities decreased Buy price target of Glenmark Pharmaceuticals Limited to 710.0 on 31 May, 2018.
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 20, 20172.00--
Aug. 3, 20162.00--
Sept. 10, 20152.00--
July 10, 20142.00--
July 18, 20132.00--
All dividends by GLENMARK